Treatment Outcomes for Childhood Acute Lymphoblastic Leukemia in Resource-Limited Settings: A Hybrid Risk-Stratified Treatment Protocol Without Minimal Residual Disease Measurement

被引：0

作者：

Alsakka, Suzan ^{[1
]}

Jneidi, Safaa ^{[1
]}

Ghanem, Khaled ^{[1
]}

机构：

[1] BASMA Pediat Oncol Unit, Damascus, Syria

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷

关键词：

ALL; children; low income; MRD;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ALL-572

引用

页码：S276 / S276

页数：1

共 50 条

[31] Validation of a registry-derived risk algorithm based on treatment protocol as a proxy for disease risk in childhood acute lymphoblastic leukemia
Gupta, Sumit
Pole, Jason D.
Guttmann, Astrid
Sung, Lillian
BMC MEDICAL RESEARCH METHODOLOGY, 2013, 13
[32] Validation of a registry-derived risk algorithm based on treatment protocol as a proxy for disease risk in childhood acute lymphoblastic leukemia
Sumit Gupta
Jason D Pole
Astrid Guttmann
Lillian Sung
BMC Medical Research Methodology, 13
[33] Correction to: High incidence of invasive fungal infection during acute myeloid leukemia treatment in a resource-limited country: clinical risk factors and treatment outcomes
Variya Nganthavee
Woraphun Phutthasakda
Kawita Atipas
Sirikul Tanpong
Teeramet Pungprasert
Dhanach Dhirachaikulpanich
Saran Krithin
Supang Tanglitanon
Warissara Jutidamrongphan
Weerapat Owattanapanich
Methee Chayakulkeeree
Ployploen Phikulsod
Supportive Care in Cancer, 2019, 27 : 3623 - 3623
[34] Genomics, Transcriptomics, and Minimal Residual Disease Detection: The Winning Team to Guide Treatment of Acute Lymphoblastic Leukemia
Segers, Heidi
Cools, Jan
BLOOD CANCER DISCOVERY, 2021, 2 (04): : 294 - 296
[35] Acute burn care in resource-limited settings: A cohort study on treatment and outcomes in a rural regional referral hospital in Tanzania
Hendriks, T. C. C.
Botman, M.
Binnerts, J. J.
Mtui, G. S.
Nuwass, E. Q.
Meij-de Vries, A.
Winters, H. A. H.
Nieuwenhuis, M. K.
van Zuijlen, P. P. M.
BURNS, 2022, 48 (08) : 1966 - 1979
[36] Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia
Rabin, Karen R.
Gramatges, M. Monica
Borowitz, Michael J.
Palla, Shana L.
Shi, Xiaodong
Margolin, Judith F.
Zweidler-McKay, Patrick A.
PEDIATRIC BLOOD & CANCER, 2012, 59 (03) : 468 - 474
[37] ABSOLUTE LYMPHOCYTE COUNTS REFINE MINIMAL RESIDUAL DISEASE-BASED RISK STRATIFICATION IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Margolin, Judith
Rabin, Karen
Gramatges, M. Monica
Borowitz, Michael
Pulla, Shana
Shi, Xiaodong
Zwiedler-McKay, Patrick
PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 707 - 708
[38] Immunophenotypic modulation during early phase of treatment of childhood acute lymphoblastic leukemia: Implication for the detection of minimal residual disease by flow cytometry.
Gaipa, G
Maglia, O
Dworzak, MN
Leoni, V
Faini, A
d'Aniello, E
Manenti, M
Bugarin, C
Ratei, R
Basso, G
Biondi, A
BLOOD, 2003, 102 (11) : 375A - 375A
[39] FLOW CYTOMETRIC EVALUATION OF MINIMAL RESIDUAL DISEASE ON DAY 15 OF INDUCTION TREATMENT IN CHILDHOOD B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Sedek, Lukasz
Sonsala, Alicja
Bulsa, Joanna
Wieczorek, Maria
Malinowska, Iwona
Derwich, Katarzyna
Trelinska, Joanna
Muszynska-Roslan, Katarzyna
Badowska, Wanda
Niedzwiecki, Maciej
Niedzielska, Ewa
Sobol, Grazyna
Wysocki, Marek
Kowalczyk, Jerzy
Mazur, Bogdan
Szczepanski, Tomasz
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2011, 80B (06) : 411 - 412
[40] Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia
Biojone, Estefania
Queiroz, Rosane De Paula
Valera, Elvis Terci
Odashima, Newton Satoro
Takayanagui, Osvaldo Massaiti
Viana, Marcos Borato
Tone, Luiz Gonzaga
Scrideli, Carlos Alberto
LEUKEMIA & LYMPHOMA, 2012, 53 (01) : 89 - U184

← 1 2 3 4 5 →